Imv Inc
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada. Show More...
-
Website https://www.imv-inc.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.08 USD
-
Last Updated 26-06-2023
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share CAD -0.38 -0.41 -0.32 -0.22 -0.26 -0.32 -0.28 -0.31 -0.5 -0.55 -0.61 Dividends CAD Payout Ratio % * Shares Mil 15.0 17.0 19.0 21.0 26.0 29.0 32.0 39.0 44.0 50.0 51.0 Book Value Per Share * USD -0.03 0.29 0.05 0.06 0.2 0.18 0.22 -0.03 Free Cash Flow Per Share * USD -0.23 -0.15 -0.19 -0.14 -0.19 -0.28 -0.41 Return on Assets % -57.54 -68.56 -116.45 -104.66 -74.87 -95.38 -84.51 -74.87 -109.79 -120.66 -107.71 Financial Leverage (Average) 2.6 1.41 2.13 1.97 1.59 85.82 2.16 2.69 5.31 3.48 Return on Equity % -158.97 -136.98 -186.56 -212.79 -126.25 -222.62 -252.27 -180.53 -411.56 -508.41 -265.73 Return on Invested Capital % -61.71 -74.43 -142.61 -148.45 -84.62 -112.76 -87.06 -85.06 -153.68 -173.7 -137.2 Interest Coverage -34.02 -42.53 -25.07 -20.86 -4.91 -11.45 -14.84 -21.09 -23.4 Current Ratio 14.28 5.11 2.83 3.69 7.93 2.52 8.2 5.79 2.57 3.06 1.57 Quick Ratio 13.94 4.87 2.56 3.56 7.76 2.41 7.94 5.5 2.22 2.59 1.23 Debt/Equity 1.43 0.17 0.5 0.49 0.4 53.61 0.87 1.02 2.17 1.49